News

2011
25 February

European drug regulator challenged over revolving door case involving former Director
1 February

Corporate funding linked to EU patient & consumer groups policy
2010
22 December

Apply now: HAI Europe recruits two interns for 2011
20 December

EMA reviews transparency criteria
1 December

HAI research on financial disclosure featured in article: European politicians' call for greater transparency
24 November

Invitation: Meeting to discuss Global Health Education (GHE) and the People's Health Movement (PHM) in Europe
25 October

ACTA, Democracy & Access to Medicines
22 October

Selling Sickness through unbranded disease awareness campaigns?
22 October

HAI Europe Statement: EMA talks the ‘conflicts of interest’ talk, but will it walk the walk?
22 October

Report: Public information as a medicines marketing tool
22 October

Systematic review of drug promotion's influence on prescribing
18 October

Doha Declaration Par 6 to be reviewed in TRIPS Council
6 October

Welfare Implications of Intellectual Property Enforcement
23 September

Dutch Minister of Health supports HAI E's financial transparency recommendations to EMA
2 September

Report exposes how Big Pharma has hijacked EU-India trade deal
30 August

In perspective: EMA comments on HAI Europe's survey of financial disclosure
25 August

Impact of HAI Europe survey results: Two weeks on
11 August

HAI Europe survey reveals new data on financial transparency of patient and consumer organisations
14 July

Open Health Forum: more room for civil society?
29 June

Priorities of the Belgian Presidency
28 June

HAI Europe recommendations for improved conflict of interest declarations at EMA
24 June

International Experts Find that Pending Anti-Counterfeiting Trade Agreement Threatens Public Interests
23 June

ISDB & MiEF criticize EMA over conflict of interest procedures
14 June

Innovation & Access at the EU High Level Event on Global Health
14 June

Review of conflict of interest policies in three European medicines regulation agencies
8 June

Medicines manufacturers have clear motives for financing the patient voice
3 June

Quito Declaration
1 June

Independent drug bulletin and assessment reports from Spain – now in English
23 May

Quito Declaration
20 May

EU Global Health Council Conclusions presented at WHA